Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.
Description
SeqOne is an advanced genomic analysis platform powered by artificial intelligence, aimed at enabling molecular laboratories, clinical teams, biologists, and geneticists to convert intricate next-generation sequencing data into quick, accurate, and actionable clinical insights that aid in personalized medicine diagnostics. By streamlining the entire genomic workflow—from handling raw sequencing data to variant interpretation and reporting—this platform automates routine tasks, integrates smoothly with laboratory systems, and employs sophisticated AI models like DiagAI to assess and prioritize disease-related variants, thereby minimizing manual labor and shortening turnaround times. SeqOne is versatile, catering to both germline and somatic analyses across various fields such as oncology, rare inherited diseases, and infectious disease detection, while it combines high-quality annotation databases and standardized interpretation protocols to ensure clinical-grade precision. Furthermore, it features an intuitive user interface that can scale securely through the cloud, making it accessible and efficient for diverse clinical environments. Ultimately, SeqOne represents a significant advancement in genomic analysis technology, fostering enhanced diagnostic capabilities in the realm of personalized medicine.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
BenevolentAI
Founded
2013
Country
Luxembourg
Website
www.benevolent.com
Vendor Details
Company Name
SeqOne
Founded
2017
Country
France
Website
www.seqone.com